The ACPA test has been used to classify the RA into two disease subsets, i.e., ACPA-positive (which includes the HLA-DR shared epitope subset) and ACPA-negative (no HLA shared epitope association is present) (195). This evidence concerns the gene PRTN3 and rheumatoid arthritis.